Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Abstract
Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [644]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
Published
16-Sep-2019
How to Cite
Breyer, R. M., Clapp, L., Coleman, R. A., Giembycz, M., Heinemann, A., Hills, R., Jones, R. L., Narumiya, S., Norel, X., Pettipher, R., Sugimoto, Y., Woodward, D. F. and Yao, C. (2019) “Prostanoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database”, IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi: 10.2218/gtopdb/F58/2019.4.
Issue
Section
Summaries
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.